1 Study Coverage 1.1 Imatinib Mesylate Product Introduction 1.2 Market by Type 1.2.1 Global Imatinib Mesylate Market Size Growth Rate by Type 1.2.2 99% Purity 1.2.3 98% Purity 1.2.4 Other 1.3 Market by Application 1.3.1 Global Imatinib Mesylate Market Size Growth Rate by Application 1.3.2 CML 1.3.3 GIST 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Imatinib Mesylate Market Size, Estimates and Forecasts 2.1.1 Global Imatinib Mesylate Revenue 2016-2027 2.1.2 Global Imatinib Mesylate Sales 2016-2027 2.2 Global Imatinib Mesylate, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Imatinib Mesylate Historical Market Size by Region (2016-2021) 2.3.1 Global Imatinib Mesylate Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Imatinib Mesylate Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Imatinib Mesylate Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Imatinib Mesylate Sales Forecast by Region (2022-2027) 2.4.2 Global Imatinib Mesylate Revenue Forecast by Region (2022-2027) 3 Global Imatinib Mesylate Competitor Landscape by Players 3.1 Global Top Imatinib Mesylate Manufacturers by Sales 3.1.1 Global Imatinib Mesylate Sales by Manufacturer (2016-2021) 3.1.2 Global Imatinib Mesylate Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Imatinib Mesylate Manufacturers by Revenue 3.2.1 Key Imatinib Mesylate Manufacturers Covered: Ranking by Revenue 3.2.2 Global Imatinib Mesylate Revenue by Manufacturers (2016-2021) 3.2.3 Global Imatinib Mesylate Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Imatinib Mesylate Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Imatinib Mesylate Revenue in 2020 3.2.6 Global Imatinib Mesylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Imatinib Mesylate Price by Manufacturers 3.4 Global Imatinib Mesylate Manufacturing Base Distribution, Product Types 3.4.1 Imatinib Mesylate Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Imatinib Mesylate Product Type 3.4.3 Date of International Manufacturers Enter into Imatinib Mesylate Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Imatinib Mesylate Market Size by Type (2016-2021) 4.1.1 Global Imatinib Mesylate Sales by Type (2016-2021) 4.1.2 Global Imatinib Mesylate Revenue by Type (2016-2021) 4.1.3 Imatinib Mesylate Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Imatinib Mesylate Market Size Forecast by Type (2022-2027) 4.2.1 Global Imatinib Mesylate Sales Forecast by Type (2022-2027) 4.2.2 Global Imatinib Mesylate Revenue Forecast by Type (2022-2027) 4.2.3 Imatinib Mesylate Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Imatinib Mesylate Market Size by Application (2016-2021) 5.1.1 Global Imatinib Mesylate Sales by Application (2016-2021) 5.1.2 Global Imatinib Mesylate Revenue by Application (2016-2021) 5.1.3 Imatinib Mesylate Price by Application (2016-2021) 5.2 Imatinib Mesylate Market Size Forecast by Application (2022-2027) 5.2.1 Global Imatinib Mesylate Sales Forecast by Application (2022-2027) 5.2.2 Global Imatinib Mesylate Revenue Forecast by Application (2022-2027) 5.2.3 Global Imatinib Mesylate Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Imatinib Mesylate Market Size YoY Growth 2016-2027 6.1.1 United States Imatinib Mesylate Sales YoY Growth 2016-2027 6.1.2 United States Imatinib Mesylate Revenue YoY Growth 2016-2027 6.1.3 United States Imatinib Mesylate Market Share in Global Market 2016-2027 6.2 United States Imatinib Mesylate Market Size by Players (International and Local Players) 6.2.1 United States Top Imatinib Mesylate Players by Sales (2016-2021) 6.2.2 United States Top Imatinib Mesylate Players by Revenue (2016-2021) 6.3 United States Imatinib Mesylate Historic Market Review by Type (2016-2021) 6.3.1 United States Imatinib Mesylate Sales Market Share by Type (2016-2021) 6.3.2 United States Imatinib Mesylate Revenue Market Share by Type (2016-2021) 6.3.3 United States Imatinib Mesylate Price by Type (2016-2021) 6.4 United States Imatinib Mesylate Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Imatinib Mesylate Sales Forecast by Type (2022-2027) 6.4.2 United States Imatinib Mesylate Revenue Forecast by Type (2022-2027) 6.4.3 United States Imatinib Mesylate Price Forecast by Type (2022-2027) 6.5 United States Imatinib Mesylate Historic Market Review by Application (2016-2021) 6.5.1 United States Imatinib Mesylate Sales Market Share by Application (2016-2021) 6.5.2 United States Imatinib Mesylate Revenue Market Share by Application (2016-2021) 6.5.3 United States Imatinib Mesylate Price by Application (2016-2021) 6.6 United States Imatinib Mesylate Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Imatinib Mesylate Sales Forecast by Application (2022-2027) 6.6.2 United States Imatinib Mesylate Revenue Forecast by Application (2022-2027) 6.6.3 United States Imatinib Mesylate Price Forecast by Application (2022-2027) 7 North America 7.1 North America Imatinib Mesylate Market Size YoY Growth 2016-2027 7.2 North America Imatinib Mesylate Market Facts & Figures by Country 7.2.1 North America Imatinib Mesylate Sales by Country (2016-2021) 7.2.2 North America Imatinib Mesylate Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Imatinib Mesylate Market Size YoY Growth 2016-2027 8.2 Asia Pacific Imatinib Mesylate Market Facts & Figures by Region 8.2.1 Asia Pacific Imatinib Mesylate Sales by Region (2016-2021) 8.2.2 Asia Pacific Imatinib Mesylate Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Imatinib Mesylate Market Size YoY Growth 2016-2027 9.2 Europe Imatinib Mesylate Market Facts & Figures by Country 9.2.1 Europe Imatinib Mesylate Sales by Country (2016-2021) 9.2.2 Europe Imatinib Mesylate Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Imatinib Mesylate Market Size YoY Growth 2016-2027 10.2 Latin America Imatinib Mesylate Market Facts & Figures by Country 10.2.1 Latin America Imatinib Mesylate Sales by Country (2016-2021) 10.2.2 Latin America Imatinib Mesylate Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Imatinib Mesylate Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Imatinib Mesylate Market Facts & Figures by Country 11.2.1 Middle East and Africa Imatinib Mesylate Sales by Country (2016-2021) 11.2.2 Middle East and Africa Imatinib Mesylate Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 GLEEVEC 12.1.1 GLEEVEC Corporation Information 12.1.2 GLEEVEC Description and Business Overview 12.1.3 GLEEVEC Imatinib Mesylate Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GLEEVEC Imatinib Mesylate Products Offered 12.1.5 GLEEVEC Recent Development 12.2 Cayman Chemical 12.2.1 Cayman Chemical Corporation Information 12.2.2 Cayman Chemical Description and Business Overview 12.2.3 Cayman Chemical Imatinib Mesylate Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Cayman Chemical Imatinib Mesylate Products Offered 12.2.5 Cayman Chemical Recent Development 12.3 Sichuan Xieli 12.3.1 Sichuan Xieli Corporation Information 12.3.2 Sichuan Xieli Description and Business Overview 12.3.3 Sichuan Xieli Imatinib Mesylate Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sichuan Xieli Imatinib Mesylate Products Offered 12.3.5 Sichuan Xieli Recent Development 12.4 Nanjing Kaihua Chemical 12.4.1 Nanjing Kaihua Chemical Corporation Information 12.4.2 Nanjing Kaihua Chemical Description and Business Overview 12.4.3 Nanjing Kaihua Chemical Imatinib Mesylate Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Nanjing Kaihua Chemical Imatinib Mesylate Products Offered 12.4.5 Nanjing Kaihua Chemical Recent Development 12.5 Zhengda Tianqing 12.5.1 Zhengda Tianqing Corporation Information 12.5.2 Zhengda Tianqing Description and Business Overview 12.5.3 Zhengda Tianqing Imatinib Mesylate Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Zhengda Tianqing Imatinib Mesylate Products Offered 12.5.5 Zhengda Tianqing Recent Development 12.11 GLEEVEC 12.11.1 GLEEVEC Corporation Information 12.11.2 GLEEVEC Description and Business Overview 12.11.3 GLEEVEC Imatinib Mesylate Sales, Revenue and Gross Margin (2016-2021) 12.11.4 GLEEVEC Imatinib Mesylate Products Offered 12.11.5 GLEEVEC Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Imatinib Mesylate Industry Trends 13.2 Imatinib Mesylate Market Drivers 13.3 Imatinib Mesylate Market Challenges 13.4 Imatinib Mesylate Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Imatinib Mesylate Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Imatinib Mesylate Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 99% Purity Table 3. Major Manufacturers of 98% Purity Table 4. Major Manufacturers of Other Table 5. Global Imatinib Mesylate Market Size Growth Rate by Application (2021-2027) & (MT) Table 6. Global Imatinib Mesylate Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Imatinib Mesylate Sales by Regions (2016-2021) & (MT) Table 8. Global Imatinib Mesylate Sales Market Share by Regions (2016-2021) Table 9. Global Imatinib Mesylate Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Imatinib Mesylate Sales Forecast by Region (2022-2027) & (MT) Table 11. Global Imatinib Mesylate Sales Market Share Forecast by Region (2022-2027) Table 12. Global Imatinib Mesylate Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Imatinib Mesylate Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Imatinib Mesylate Sales by Manufacturers (2016-2021) (MT) Table 15. Global Imatinib Mesylate Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Imatinib Mesylate Manufacturers by Revenue (US$ Million) in 2020 Table 17. Imatinib Mesylate Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Imatinib Mesylate Revenue Share by Manufacturers (2016-2021) Table 19. Global Imatinib Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Imatinib Mesylate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imatinib Mesylate as of 2020) Table 21. Key Manufacturers Imatinib Mesylate Price (2016-2021) (USD/MT) Table 22. Imatinib Mesylate Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Imatinib Mesylate Product Type Table 24. Date of International Manufacturers Enter into Imatinib Mesylate Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Imatinib Mesylate Sales by Type (2016-2021) (MT) Table 27. Global Imatinib Mesylate Sales Share by Type (2016-2021) Table 28. Global Imatinib Mesylate Revenue by Type (2016-2021) (US$ Million) Table 29. Global Imatinib Mesylate Revenue Share by Type (2016-2021) Table 30. Imatinib Mesylate Average Selling Price (ASP) by Type (2016-2021) & (USD/MT) Table 31. Global Imatinib Mesylate Sales Forecast by Type (2022-2027) & (MT) Table 32. Global Imatinib Mesylate Sales Market Share Forecast by Type (2022-2027) Table 33. Global Imatinib Mesylate Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Imatinib Mesylate Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Imatinib Mesylate Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT) Table 36. Global Imatinib Mesylate Sales by Application (2016-2021) (MT) Table 37. Global Imatinib Mesylate Sales Share by Application (2016-2021) Table 38. Global Imatinib Mesylate Revenue by Application (2016-2021) (US$ Million) Table 39. Global Imatinib Mesylate Revenue Share by Application (2016-2021) Table 40. Imatinib Mesylate Average Selling Price (ASP) by Application (2016-2021) & (USD/MT) Table 41. Global Imatinib Mesylate Sales Forecast by Application (2022-2027) & (MT) Table 42. Global Imatinib Mesylate Sales Market Share Forecast by Application (2022-2027) Table 43. Global Imatinib Mesylate Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Imatinib Mesylate Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Imatinib Mesylate Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT) Table 46. United States Imatinib Mesylate Sales (MT) of Key Companies (2016-2021) Table 47. United States Imatinib Mesylate Sales Share by Company (2016-2021) Table 48. United States Imatinib Mesylate Revenue (US$ Million) by Company (2016-2021) Table 49. United States Imatinib Mesylate Revenue Share by Company (2016-2021) Table 50. United States Imatinib Mesylate Sales (MT) by Type (2016-2021) Table 51. United States Imatinib Mesylate Sales Share by Type (2016-2021) Table 52. United States Imatinib Mesylate Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. United States Imatinib Mesylate Price (USD/MT) by Type (2016-2021) Table 54. United States Imatinib Mesylate Sales (MT) by Type (2022-2027) Table 55. United States Imatinib Mesylate Sales Share by Type (2022-2027) Table 56. United States Imatinib Mesylate Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. United States Imatinib Mesylate Revenue Share by Type (2022-2027) Table 58. United States Imatinib Mesylate Price (USD/MT) by Type (2022-2027) Table 59. United States Imatinib Mesylate Sales (MT) by Application (2016-2021) Table 60. United States Imatinib Mesylate Sales Share by Application (2016-2021) Table 61. United States Imatinib Mesylate Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. United States Imatinib Mesylate Price (USD/MT) by Application (2016-2021) Table 63. United States Imatinib Mesylate Sales (MT) by Application (2022-2027) Table 64. United States Imatinib Mesylate Sales Share by Application (2022-2027) Table 65. United States Imatinib Mesylate Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. United States Imatinib Mesylate Revenue Share by Application (2022-2027) Table 67. United States Imatinib Mesylate Price (USD/MT) by Application (2022-2027) Table 68. North America Imatinib Mesylate Sales by Country (2016-2021) & (MT) Table 69. North America Imatinib Mesylate Sales Market Share by Country (2016-2021) Table 70. North America Imatinib Mesylate Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Imatinib Mesylate Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Imatinib Mesylate Sales by Region (2016-2021) & (MT) Table 73. Asia Pacific Imatinib Mesylate Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Imatinib Mesylate Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Imatinib Mesylate Revenue Market Share by Region (2016-2021) Table 76. Europe Imatinib Mesylate Sales by Country (2016-2021) & (MT) Table 77. Europe Imatinib Mesylate Sales Market Share by Country (2016-2021) Table 78. Europe Imatinib Mesylate Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Imatinib Mesylate Revenue Market Share by Country (2016-2021) Table 80. Latin America Imatinib Mesylate Sales by Country (2016-2021) & (MT) Table 81. Latin America Imatinib Mesylate Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Imatinib Mesylate Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Imatinib Mesylate Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Imatinib Mesylate Sales by Country (2016-2021) & (MT) Table 85. Middle East and Africa Imatinib Mesylate Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Imatinib Mesylate Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Imatinib Mesylate Revenue Market Share by Country (2016-2021) Table 88. GLEEVEC Corporation Information Table 89. GLEEVEC Description and Business Overview Table 90. GLEEVEC Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 91. GLEEVEC Imatinib Mesylate Product Table 92. GLEEVEC Recent Development Table 93. Cayman Chemical Corporation Information Table 94. Cayman Chemical Description and Business Overview Table 95. Cayman Chemical Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 96. Cayman Chemical Product Table 97. Cayman Chemical Recent Development Table 98. Sichuan Xieli Corporation Information Table 99. Sichuan Xieli Description and Business Overview Table 100. Sichuan Xieli Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 101. Sichuan Xieli Product Table 102. Sichuan Xieli Recent Development Table 103. Nanjing Kaihua Chemical Corporation Information Table 104. Nanjing Kaihua Chemical Description and Business Overview Table 105. Nanjing Kaihua Chemical Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 106. Nanjing Kaihua Chemical Product Table 107. Nanjing Kaihua Chemical Recent Development Table 108. Zhengda Tianqing Corporation Information Table 109. Zhengda Tianqing Description and Business Overview Table 110. Zhengda Tianqing Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 111. Zhengda Tianqing Product Table 112. Zhengda Tianqing Recent Development Table 113. Imatinib Mesylate Market Trends Table 114. Imatinib Mesylate Market Drivers Table 115. Imatinib Mesylate Market Challenges Table 116. Imatinib Mesylate Market Restraints Table 117. Imatinib Mesylate Customers List Table 118. Imatinib Mesylate Distributors List Table 119. Research Programs/Design for This Report Table 120. Key Data Information from Secondary Sources Table 121. Key Data Information from Primary Sources List of Figures Figure 1. Imatinib Mesylate Product Picture Figure 2. Global Imatinib Mesylate Sales Market Share by Type in 2020 & 2027 Figure 3. 99% Purity Product Picture Figure 4. 98% Purity Product Picture Figure 5. Other Product Picture Figure 6. Global Imatinib Mesylate Sales Market Share by Application in 2020 & 2027 Figure 7. CML Figure 8. GIST Figure 9. Other Figure 10. Imatinib Mesylate Report Years Considered Figure 11. Global Imatinib Mesylate Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Imatinib Mesylate Market Size 2016-2027 (US$ Million) Figure 13. Global Imatinib Mesylate Sales 2016-2027 (MT) Figure 14. Global Imatinib Mesylate Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Imatinib Mesylate Sales Market Share by Region (2016-2021) Figure 16. Global Imatinib Mesylate Sales Market Share by Region in 2020 Figure 17. Global Imatinib Mesylate Revenue Market Share by Region (2016-2021) Figure 18. Global Imatinib Mesylate Revenue Market Share by Region in 2020 Figure 19. Global Imatinib Mesylate Sales Share by Manufacturer in 2020 Figure 20. The Top 10 and 5 Players Market Share by Imatinib Mesylate Revenue in 2020 Figure 21. Imatinib Mesylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Imatinib Mesylate Sales Market Share by Type (2016-2021) Figure 23. Global Imatinib Mesylate Sales Market Share by Type in 2020 Figure 24. Global Imatinib Mesylate Revenue Market Share by Type (2016-2021) Figure 25. Global Imatinib Mesylate Revenue Market Share by Type in 2020 Figure 26. Global Imatinib Mesylate Sales Market Share by Application (2016-2021) Figure 27. Global Imatinib Mesylate Sales Market Share by Application in 2020 Figure 28. Global Imatinib Mesylate Revenue Market Share by Application (2016-2021) Figure 29. Global Imatinib Mesylate Revenue Market Share by Application in 2020 Figure 30. United States Imatinib Mesylate Sales Growth Rate 2016-2027 (MT) Figure 31. United States Imatinib Mesylate Revenue Growth Rate 2016-2027 (US$ Million) Figure 32. United States Imatinib Mesylate Market Share in Global Market 2016-2027 Figure 33. United States 5 and 10 Largest Imatinib Mesylate Players Market Share by Revenue in Imatinib Mesylate in 2020 Figure 34. United States Imatinib Mesylate Revenue Share by Type (2016-2021) Figure 35. United States Imatinib Mesylate Revenue Growth Rate by Type in 2016 & 2020 Figure 36. United States Imatinib Mesylate Revenue Share by Application (2016-2021) Figure 37. United States Imatinib Mesylate Revenue Growth Rate by Application in 2016 & 2020 Figure 38. North America Imatinib Mesylate Sales Growth Rate 2016-2021 (MT) Figure 39. North America Imatinib Mesylate Revenue Growth Rate 2016-2021 (US$ Million) Figure 40. North America Imatinib Mesylate Sales Market Share by Country in 2020 Figure 41. North America Imatinib Mesylate Revenue Market Share by Country in 2020 Figure 42. U.S. Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 43. U.S. Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Canada Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 45. Canada Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Europe Imatinib Mesylate Sales Growth Rate 2016-2021 (MT) Figure 47. Europe Imatinib Mesylate Revenue Growth Rate 2016-2021 (US$ Million) Figure 48. Europe Imatinib Mesylate Sales Market Share by Country in 2020 Figure 49. Europe Imatinib Mesylate Revenue Market Share by Country in 2020 Figure 50. Germany Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 51. Germany Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. France Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 53. France Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. U.K. Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 55. U.K. Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Italy Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 57. Italy Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Russia Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 59. Russia Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Asia Pacific Imatinib Mesylate Sales Growth Rate 2016-2021 (MT) Figure 61. Asia Pacific Imatinib Mesylate Revenue Growth Rate 2016-2021 (US$ Million) Figure 62. Asia Pacific Imatinib Mesylate Sales Market Share by Region in 2020 Figure 63. Asia Pacific Imatinib Mesylate Revenue Market Share by Region in 2020 Figure 64. China Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 65. China Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Japan Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 67. Japan Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. South Korea Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 69. South Korea Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. India Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 71. India Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Australia Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 73. Australia Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Taiwan Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 75. Taiwan Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Indonesia Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 77. Indonesia Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Thailand Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 79. Thailand Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Malaysia Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 81. Malaysia Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Philippines Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 83. Philippines Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Vietnam Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 85. Vietnam Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Imatinib Mesylate Sales Growth Rate 2016-2021 (MT) Figure 87. Latin America Imatinib Mesylate Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Imatinib Mesylate Sales Market Share by Country in 2020 Figure 89. Latin America Imatinib Mesylate Revenue Market Share by Country in 2020 Figure 90. Mexico Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 91. Mexico Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 93. Brazil Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 95. Argentina Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Imatinib Mesylate Sales Growth Rate 2016-2021 (MT) Figure 97. Middle East and Africa Imatinib Mesylate Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Imatinib Mesylate Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Imatinib Mesylate Revenue Market Share by Country in 2020 Figure 100. Turkey Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 101. Turkey Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 103. Saudi Arabia Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. U.A.E Imatinib Mesylate Sales Growth Rate (2016-2021) (MT) Figure 105. U.A.E Imatinib Mesylate Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Imatinib Mesylate Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

GLEEVEC Cayman Chemical Sichuan Xieli Nanjing Kaihua Chemical Zhengda Tianqing